Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Radko-Juettner S, Yue H, Myers JA, Carter RD, Robertson AN, Mittal P, Zhu Z, Hansen BS, Donovan KA, Hunkeler M, Rosikiewicz W, Wu Z, McReynolds MG, Roy Burman SS, Schmoker AM, Mageed N, Brown SA, Mobley RJ, Partridge JF, Stewart EA, Pruett-Miller SM, Nabet B, Peng J, Gray NS, Fischer ES, Roberts CWM. Radko-Juettner S, et al. Among authors: mittal p. Nature. 2024 Apr;628(8007):442-449. doi: 10.1038/s41586-024-07250-1. Epub 2024 Mar 27. Nature. 2024. PMID: 38538798
Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Radko-Juettner S, Yue H, Myers JA, Carter RD, Robertson AN, Mittal P, Zhu Z, Hansen BS, Donovan KA, Hunkeler M, Rosikiewicz W, Wu Z, McReynolds MG, Roy Burman SS, Schmoker AM, Mageed N, Brown SA, Mobley RJ, Partridge JF, Stewart EA, Pruett-Miller SM, Nabet B, Peng J, Gray NS, Fischer ES, Roberts CWM. Radko-Juettner S, et al. Among authors: mittal p. Nature. 2024 May;629(8012):E12. doi: 10.1038/s41586-024-07402-3. Nature. 2024. PMID: 38684813 No abstract available.
Natural products in the management of neurodegenerative diseases.
Goyal R, Mittal P, Gautam RK, Kamal MA, Perveen A, Garg V, Alexiou A, Saboor M, Haque S, Farhana A, Papadakis M, Ashraf GM. Goyal R, et al. Among authors: mittal p. Nutr Metab (Lond). 2024 May 16;21(1):26. doi: 10.1186/s12986-024-00800-4. Nutr Metab (Lond). 2024. PMID: 38755627 Free PMC article. Review.
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
Charnalia M, Chopra S, Mulani J, Popat P, Rath S, Thomeer M, Mittal P, Gupta A, Boere I, Gupta S, Nout RA. Charnalia M, et al. Among authors: mittal p. Int J Gynecol Cancer. 2024 Apr 22:ijgc-2024-005336. doi: 10.1136/ijgc-2024-005336. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38649234
Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data.
Kashid SR, Gurram L, Pullan S, Chopra S, Mittal P, Ghadi Y, Dheera A, Scaria L, Kohle S, Kadam S, Ghosh J, Rath S, Gupta S, Mahantshetty U. Kashid SR, et al. Among authors: mittal p. Brachytherapy. 2024 Apr 18:S1538-4721(24)00047-3. doi: 10.1016/j.brachy.2024.03.006. Online ahead of print. Brachytherapy. 2024. PMID: 38641455
The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries.
WHO ACTION Trials Collaborators. WHO ACTION Trials Collaborators. Trials. 2024 Apr 12;25(1):258. doi: 10.1186/s13063-024-07941-0. Trials. 2024. PMID: 38609983 Free PMC article.
707 results